Hemispherx BioPharma, Inc. (HEB) financial statements (2020 and earlier)

Company profile

Business Address 2117 SW HIGHWAY 484
OCALA, FL 32801
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments102691618
Cash and cash equivalents1012221
Short-term investments  1371417
Receivables110    
Prepaid expense     00
Assets held-for-sale, not part of disposal group  11 
Other undisclosed current assets82102  
Total current assets:10447111719
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment789101155
Intangible assets, net (including goodwill)1111111
Intangible assets, net (excluding goodwill)1111111
Other noncurrent assets1112000
Other undisclosed noncurrent assets     77
Total noncurrent assets:10101112121313
TOTAL ASSETS:20141419232932
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1232242
Accounts payable0111121
Accrued liabilities0122121
Debt0   000
Other undisclosed current liabilities 4     
Total current liabilities:1532243
Noncurrent Liabilities
Long-term debt and lease obligation222   0
Long-term debt, excluding current maturities222    
Capital lease obligations     0
Operating lease, liability0
Liabilities, other than long-term debt      0
Derivative instruments and hedges, liabilities      0
Total noncurrent liabilities:222   0
Total liabilities:3852243
Stockholders' equity
Stockholders' equity attributable to parent, including:135915202529
Common stock0000000
Additional paid in capital340324317316313303290
Accumulated other comprehensive income (loss) (0)0(0)(0)(0)(0)
Accumulated deficit(328)(319)(309)(301)(293)(278)(260)
Other undisclosed stockholders' equity attributable to parent1      
Total stockholders' equity:135915202529
Other undisclosed liabilities and equity4111   
TOTAL LIABILITIES AND EQUITY:20141419232932

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues0000000
Revenue, net00000
Cost of revenue(2)(2)(1)(1)(2)(1)(1)
Cost of goods and services sold(1)(1)(1)(1)(2)  
Gross profit:(2)(1)(1)(1)(1)(1)(1)
Operating expenses(11)(10)(11)(13)(15)(18)(16)
Operating loss:(12)(11)(11)(14)(17)(19)(17)
Nonoperating income
(Other Nonoperating income)
      1
Interest and debt expense(0)(1)(0) (0)(0)(0)
Loss before gain (loss) on sale of properties:(13)(12)(12)(14)(17)(19)(16)
Other undisclosed net income     20
Net loss:(13)(12)(12)(14)(17)(17)(16)
Other undisclosed net income attributable to parent32361  
Net loss available to common stockholders, diluted:(10)(10)(8)(8)(15)(17)(16)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(13)(12)(12)(14)(17)(17)(16)
Other comprehensive loss     (17)(16)
Other undisclosed comprehensive income     1716
Comprehensive loss:(13)(12)(12)(14)(17)(17)(16)
Other undisclosed comprehensive income, net of tax, attributable to parent32361  
Comprehensive loss, net of tax, attributable to parent:(10)(10)(8)(7)(15)(17)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: